Hong G, Sun P, Chung C, Park D, et al. Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer. J Cancer Res Clin Oncol 2022 Dec 6. doi: 10.1007/s00432-022-04500.
PMID: 36472770